Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients.

Romeo V, Pegoraro E, Squarzanti F, Sorarù G, Ferrati C, Ermani M, Zucchetta P, Chierichetti F, Angelini C.

Neurol Sci. 2010 Dec;31(6):757-63. doi: 10.1007/s10072-010-0406-2. Epub 2010 Sep 15.

PMID:
20842397
2.

Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.

Romeo V, Pegoraro E, Ferrati C, Squarzanti F, Sorarù G, Palmieri A, Zucchetta P, Antunovic L, Bonifazi E, Novelli G, Trevisan CP, Ermani M, Manara R, Angelini C.

J Neurol. 2010 Aug;257(8):1246-55. doi: 10.1007/s00415-010-5498-3. Epub 2010 Mar 11.

PMID:
20221771
3.

Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.

Weber YG, Roebling R, Kassubek J, Hoffmann S, Rosenbohm A, Wolf M, Steinbach P, Jurkat-Rott K, Walter H, Reske SN, Lehmann-Horn F, Mottaghy FM, Lerche H.

Neurology. 2010 Apr 6;74(14):1108-17. doi: 10.1212/WNL.0b013e3181d8c35f. Epub 2010 Mar 10.

PMID:
20220122
4.

Cerebral Hypoperfusion in Hereditary Coproporphyria (HCP): A Single Photon Emission Computed Tomography (SPECT) Study.

Valle G, Guida CC, Nasuto M, Totaro M, Aucella F, Frusciante V, Di Mauro L, Potenza A, Savino M, Stanislao M, Popolizio T, Guglielmi G, Giagulli VA, Guastamacchia E, Triggiani V.

Endocr Metab Immune Disord Drug Targets. 2016;16(1):39-46.

5.

Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis.

Nelissen N, Van Paesschen W, Baete K, Van Laere K, Palmini A, Van Billoen H, Dupont P.

Neuroimage. 2006 Aug 15;32(2):684-95. Epub 2006 Jun 9.

PMID:
16762567
7.

Positron emission tomography in myotonic dystrophy.

Mielke R, Herholz K, Fink G, Ritter D, Heiss WD.

Psychiatry Res. 1993 Jun;50(2):93-9.

PMID:
8378492
8.

Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.

Yoshida K, Ogasawara K, Saura H, Saito H, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Ogawa A.

J Neurosurg. 2015 Dec;123(6):1546-54. doi: 10.3171/2014.12.JNS142339. Epub 2015 Jul 31.

PMID:
26230467
9.

Crossed aphasia. Functional brain imaging with PET or SPECT.

Bakar M, Kirshner HS, Wertz RT.

Arch Neurol. 1996 Oct;53(10):1026-32. Review.

PMID:
8859065
10.

A comparative study of brain perfusion single-photon emission computed tomography and magnetic resonance imaging in patients with post-traumatic anosmia.

Atighechi S, Salari H, Baradarantar MH, Jafari R, Karimi G, Mirjali M.

Am J Rhinol Allergy. 2009 Jul-Aug;23(4):409-12. doi: 10.2500/ajra.2009.23.3345.

PMID:
19671257
11.

Unique discrepancy between cerebral blood flow and glucose metabolism in hemimegalencephaly.

Uematsu M, Haginoya K, Togashi N, Hino-Fukuyo N, Nakayama T, Kikuchi A, Abe Y, Wakusawa K, Matsumoto Y, Kakisaka Y, Kobayashi T, Hirose M, Yokoyama H, Iinuma K, Iwasaki M, Nakasato N, Kaneta T, Akasaka M, Kamei A, Tsuchiya S.

Epilepsy Res. 2010 Dec;92(2-3):201-8. doi: 10.1016/j.eplepsyres.2010.09.010. Epub 2010 Oct 20.

PMID:
20965696
12.

Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis.

Piga M, Serra A, Deiana L, Loi GL, Satta L, Di Liberto M, Mariotti S.

Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1639-44. Epub 2004 Jul 31.

PMID:
15290119
13.

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N.

Radiology. 2005 Mar;234(3):851-9.

14.

99-mTc-HMPAO single photon emission computed tomography examinations in genetically determined neurometabolic disorders.

László A, Ambrus E, Vörös E, Svékus A, Kóbor J, Bereg E, Palatka J, Pávics L.

Ideggyogy Sz. 2009 May 30;62(5-6):168-77.

PMID:
19579665
15.

Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT.

Neuromuscul Disord. 2003 Dec;13(10):813-21.

PMID:
14678804
16.
17.

Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism.

Sansone V, Meola G, Perani D, Fazio F, Garibotto V, Cotelli M, Cotelli M, Vitelli E.

J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):425-6. No abstract available.

18.

Dynamic imaging in mild traumatic brain injury: support for the theory of medial temporal vulnerability.

Umile EM, Sandel ME, Alavi A, Terry CM, Plotkin RC.

Arch Phys Med Rehabil. 2002 Nov;83(11):1506-13.

PMID:
12422317
19.

Neuronuclear assessment of patients with epilepsy.

Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W.

Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004. Review.

PMID:
18514079
20.

Brain perfusion single photon emission computed tomography findings in patients with posttraumatic anosmia and comparison with radiological imaging.

Eftekhari M, Assadi M, Kazemi M, Saghari M, Mojtahedi A, Fard-Esfahani A, Sichani BF, Beiki D.

Am J Rhinol. 2006 Nov-Dec;20(6):577-81.

PMID:
17181096

Supplemental Content

Support Center